Skip to content

The intense excitement and the unsettling fear of using psychedelic substances

Psychologist Tony Bossis, a key figure in the 2016 research that identified stress reduction in cancer patients following a solitary dose of psilocybin, expresses a keen interest in the overlap between profound religious experiences and psychedelic ones.

Exploring the Thrill and Intensity of Hallucinogenic Substances
Exploring the Thrill and Intensity of Hallucinogenic Substances

The intense excitement and the unsettling fear of using psychedelic substances

Tony Bossis' Psychedelic Research at NYU School of Medicine

Tony Bossis, a researcher at the NYU School of Medicine, is making waves in the field of psychedelic research. His current focus is on understanding the effects of psychedelics, particularly psilocybin, on consciousness, spiritual experiences, and emotional well-being.

Bossis' work has gained significant attention in the scientific community, with numerous publications detailing his findings. One of his most notable studies, published in 2025, explored psilocybin’s influence on religious and spiritual attitudes and behaviors among clergy from major world religions. The research found that guided psilocybin sessions can profoundly enhance spiritual life and emotional health.

In addition to this, Bossis' research interests include mapping psychedelic experiences onto mystical experiences of great religions. He is particularly intrigued by these connections and has presented scholarly work on this topic at prestigious forums, such as the New York Academy of Sciences.

While the search results do not explicitly mention recent findings by Bossis specifically on psilocybin and stress reduction in cancer patients, his broader work in psychedelic-assisted therapy includes applications for psychological distress associated with serious illnesses, including cancer.

One of Bossis' most significant findings to date is a 2016 study where he served as a lead investigator. This study found profound stress reduction in cancer patients after a single dose of psilocybin. However, more detailed or the latest clinical trial results on cancer and stress may be found in academic databases and clinical trial registries.

Bossis' current research also includes exploring the use of psychedelics in the treatment of depression and anxiety. As he continues to investigate the therapeutic potential of psychedelics, his work is contributing to a growing body of evidence supporting their therapeutic potential.

In summary, Tony Bossis' research at the NYU School of Medicine is focused on understanding the effects of psychedelics, particularly psilocybin, on consciousness, spiritual experiences, and emotional well-being. His notable findings include the enhancement of spiritual life and emotional health in religious leaders following supported psilocybin sessions, and profound stress reduction in cancer patients after a single dose of psilocybin. While more recent findings on stress reduction in cancer patients may not be directly available, his work continues to contribute significantly to the field of psychedelic research.

Tony Bossis' research expands beyond spiritual well-being, delving into the realms of health-and-wellness and mental-health. His work on psilocybin shows potential in various therapies-and-treatments, notably reducing stress in cancer patients, and may offer promising solutions for depression and anxiety.

Read also:

    Latest